1-20 of 50
Mary-Elizabeth M. Percival
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial Combining Venetoclax with G-CSF, Cladribine, Cytarabine, and Mitoxantrone (CLAG-M) for Patients with High-Grade Myeloid Neoplasms

Suravi Raychaudhuri, Ted Gooley, Zach Gill, Allegra Rasmussen, Anna B. Halpern, Jacob S. Appelbaum, Cristina Maria Ghiuzeli, Paul C. Hendrie, Ryan D Cassaday, Roland B. Walter, Elihu Estey, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2897.
https://doi.org/10.1182/blood-2023-181582
Published: 2023
Journal Articles

Shotgun Sequencing of Multi-Site Oral and Colonic Microbiota in Patients with AML: Site-Specific Patterns and Microbiota Decompartmentalization

Armin Rashidi, Suravi Raychaudhuri, Hakan Gem, Kristopher A Kerns, Jacob S. Appelbaum, Mary-Elizabeth M. Percival, Anna B. Halpern, Alexander Zevin, Samuel Minot, David R Dean, Roland B. Walter, Jeffrey S McLean
Journal: Blood
Blood (2023) 142 (Supplement 1): 2273.
https://doi.org/10.1182/blood-2023-185078
Published: 2023
Journal Articles

Prognostic Value of Copy Number Aberrations and Copy Neutral Loss of Heterozygosity in Acute Myeloid Leukemia

Suravi Raychaudhuri, Ted Gooley, Xiaoyu Qu, Carole Shaw, Kathryn Russell, Rutu D. Vyas, Jacob S. Appelbaum, Anna B. Halpern, Roland B. Walter, Min Fang, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2945.
https://doi.org/10.1182/blood-2023-184402
Published: 2023
Journal Articles

Evaluation of ECOG Performance Status at Diagnosis and Relapse in Patients with Acute Myeloid Leukemia

Michelle Y. Zhang, Carole Shaw, Kathryn Russell, Rutu D. Vyas, Anna B. Halpern, Jacob S. Appelbaum, Cristina Maria Ghiuzeli, Roland B. Walter, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2844.
https://doi.org/10.1182/blood-2023-174343
Published: 2023
Journal Articles

Treatment Outcomes for Adults with Mixed Phenotypic Acute Leukemia: A Large Single-Center Retrospective Study

Jennifer J. Huang, Jacob S. Appelbaum, Kathryn Russell, Carole Shaw, Ashley M. Eckel, Xueyan Chen, Rutu D. Vyas, Paul C. Hendrie, Anna B. Halpern, Raya Mawad, Ryan D Cassaday, Roland B. Walter, Mary-Elizabeth M. Percival, Cristina Maria Ghiuzeli
Journal: Blood
Blood (2023) 142 (Supplement 1): 2838.
https://doi.org/10.1182/blood-2023-188461
Published: 2023
Journal Articles

Class III Obesity Is Associated with Worse Overall Survival in Previously Untreated Younger Patients with Acute Myeloid Leukemia Enrolled on SWOG 1203

Michelle Y. Zhang, Megan Othus, Kerry K McMillen, Harry P. Erba, Guillermo Garcia-Manero, John Pagel, Mohamed Sorror, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2023) 142 (Supplement 1): 2863.
https://doi.org/10.1182/blood-2023-189455
Published: 2023
Journal Articles

Allogeneic Hematopoietic Cell Transplantation in the 7 th Decade of Life and Beyond

Mary-Elizabeth M. Percival, Ted Gooley, Chris Davis, Ryan S. Basom, Stephanie J. Lee, Frederick R. Appelbaum, Mohamed Sorror
Journal: Blood
Blood (2023) 142 (Supplement 1): 3608.
https://doi.org/10.1182/blood-2023-185037
Published: 2023
Journal Articles

Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms

Jordan Gauthier, Bianca Furtuna, Jacopo Mangiavacchi, Shahrzad Gholami, Juan Lavista Ferres, Rahul Dodhia, Amir T. Fathi, Andrew M. Brunner, Aaron T. Gerds, Mikkael A. Sekeres, Bruno C. Medeiros, Eunice S. Wang, Paul J Shami, Kehinde Adekola, Selina M. Luger, Maria R. Baer, David A Rizzieri, Tanya Wildes, Jamie L. Koprivnikar, Julie Smith, Mitchell A. Garrison, Kiarash Kojouri, Frederick R. Appelbaum, Mary-Elizabeth M. Percival, Stephanie J. Lee, Mohamed L. Sorror
Journal: Blood
Blood (2022) 140 (Supplement 1): 5254–5257.
https://doi.org/10.1182/blood-2022-165437
Published: 2022
Journal Articles

Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)

Piyanuch Kongtim, Mary-Elizabeth M. Percival, Timothy J Martins, Guangrong Qin, Niall Curley, Kelda M. Gardner, Sylvia Chien, Jin Dai, Vivian G. Oehler, C. Anthony Blau, Paul C. Hendrie, Ryan D. Cassaday, Anna B. Halpern, Bart L. Scott, Roland B. Walter, Heather Smith, Guido Marcucci, Pamela S. Becker
Journal: Blood
Blood (2022) 140 (Supplement 1): 1200–1202.
https://doi.org/10.1182/blood-2022-165801
Published: 2022
Journal Articles

Trial in Progress: Phase 1b/2 Study of Alrizomadlin (APG-115), Alone or Combined with 5-Azacitidine (AZA), in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), or Myelodysplastic Syndrome (MDS)

Tapan M. Kadia, Christopher Benton, Harry P. Erba, Mitul Gandhi, Moshe Y. Levy, Mary-Elizabeth M. Percival, Matthew Ulrickson, Habte Yimer, Min Yu, Zi Chen, Jing Wang, Mingyu Li, Mohammad Ahmad, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2022) 140 (Supplement 1): 11659–11660.
https://doi.org/10.1182/blood-2022-162627
Published: 2022
Journal Articles

Revised Prognostic Index for Patients with Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms in First Relapse

Noam E. Kopmar, Megan Othus, Olivia Gilbert, Kelda Schonhoff, Carole M. Shaw, Kathryn Russell, Anna B. Halpern, Jacob S. Appelbaum, Roland B. Walter, Paul C. Hendrie, Bart L. Scott, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2022) 140 (Supplement 1): 3199–3201.
https://doi.org/10.1182/blood-2022-166526
Published: 2022
Journal Articles

Prognostic Impact of Secondary Versus De Novo Ontogeny in Acute Myeloid Leukemia (AML) Is Predominantly Accounted for By the European Leukemianet (ELN) 2022 Risk Classification

Michael J. Hochman, Megan Othus, Robert P. Hasserjian, Alexander J. Ambinder, Andrew M. Brunner, Mary-Elizabeth M. Percival, Christopher S. Hourigan, Ronan Swords, Amy E. DeZern, Elihu H. Estey, Judith E. Karp
Journal: Blood
Blood (2022) 140 (Supplement 1): 1430–1432.
https://doi.org/10.1182/blood-2022-164739
Published: 2022
Journal Articles

Time to Count Recovery after Post-Remission Chemotherapy in AML Patients

Gabrielle Paras, Megan Othus, Carole M. Shaw, Katie Russell, Anna B. Halpern, Jacob S. Appelbaum, Paul C. Hendrie, Roland B. Walter, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2022) 140 (Supplement 1): 6080–6081.
https://doi.org/10.1182/blood-2022-157586
Published: 2022
Journal Articles

Dose-Adjusted EPOCH Versus Hypercvad As Initial Treatment for Adults with Acute Lymphoblastic Leukemia (ALL): A Retrospective Matched Cohort Comparison

Lucas Zarling, Philip Stevenson, Lorinda A. Soma, Christen H. Martino, Mary-Elizabeth M. Percival, Anna B. Halpern, Cristina Ghiuzeli, Pamela S. Becker, Vivian G. Oehler, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Elihu H. Estey, Ryan D. Cassaday
Journal: Blood
Blood (2022) 140 (Supplement 1): 6046–6048.
https://doi.org/10.1182/blood-2022-170016
Published: 2022
Journal Articles

Addition of Sorafenib to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms Independent of FLT3-Mutation Status: Final Results of a Phase 1/2 Study

Anna B. Halpern, Eduardo P Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M. Percival, Ryan D. Cassaday, Vivian G. Oehler, Pamela S. Becker, Jacob S. Appelbaum, Janis L. Abkowitz, Johnnie J. Orozco, Sioban B. Keel, Paul C. Hendrie, Bart L. Scott, Cristina Ghiuzeli, Roland B. Walter, Elihu H. Estey
Journal: Blood
Blood (2022) 140 (Supplement 1): 8999–9001.
https://doi.org/10.1182/blood-2022-159882
Published: 2022
Journal Articles

Time-Dependent Prediction of Relapse in Patients with Acute Myeloid Leukemia

John J. Lim, Megan Othus, Carole M. Shaw, Kathryn Russell, Anna B. Halpern, Jacob S. Appelbaum, Roland B. Walter, Mary-Elizabeth M. Percival
Journal: Blood
Blood (2022) 140 (Supplement 1): 132–134.
https://doi.org/10.1182/blood-2022-169801
Published: 2022
Journal Articles

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Molly Tokaz, Helen Baldomero, Andrew J Cowan, Wael Saber, Hildegard T. Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastian Galeano, Shinichiro Okamoto, Naeem A. Chaudhri, Amado J Karduss, Fabio Ciceri, Vergilio Rensi Colturato, Selim Corbacioglu, Alaa M. Elhaddad, Lisa Force, Cristobal Augusto Frutos Ortiz, Andres Gomez-De Leon, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius YL Ho, Xiao-Jun Huang, Benjamin Jacobs, Heeje Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary-Elizabeth M. Percival, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor-Sheng Ko, Anderson Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A Snowden, Daniel J. Weisdorf, Jakob R. Passweg, Marcelo C Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser, Martina Perdomo
Journal: Blood
Blood (2022) 140 (Supplement 1): 8146–8149.
https://doi.org/10.1182/blood-2022-158338
Published: 2022
Journal Articles

Prognostic Significance of Chromosomal Genomic Array Testing in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia

Noam E. Kopmar, Xiaoyu Qu, Yajuan J. Liu, Ted A. Gooley, Lucas Zarling, Mary-Elizabeth M. Percival, Cristina Ghiuzeli, Min Fang, Ryan D. Cassaday
Journal: Blood
Blood (2022) 140 (Supplement 1): 9196–9197.
https://doi.org/10.1182/blood-2022-168183
Published: 2022
Journal Articles

Reduced-Intensity Therapy with Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Yields Durable Remissions in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Final Results of a Phase II Trial

Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Olga Sala-Torra, Philip A. Stevenson, Christen H. Martino, Yajuan J. Liu, Min Fang, Mary-Elizabeth M. Percival, Anna B. Halpern, Pamela S. Becker, Vivian G. Oehler, Andrei R Shustov, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Jerry P. Radich, Lorinda A. Soma, Elihu H. Estey
Journal: Blood
Blood (2021) 138 (Supplement 1): 4397.
https://doi.org/10.1182/blood-2021-145648
Published: 2021
Journal Articles

A Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm

Colin D. Godwin, Megan Othus, Mary-Elizabeth M. Percival, Paul C. Hendrie, Bart L. Scott, Jacob S. Appelbaum, Anna B. Halpern, Vivian G. Oehler, Johnnie J. Orozco, Sioban B. Keel, Janis L. Abkowitz, Jason P. Cooper, Ryan D. Cassaday, Kaysey F. Orlowski, Anise J. Marshall, Clarisa N. Brown, Elihu H. Estey, Roland B. Walter
Journal: Blood
Blood (2021) 138 (Supplement 1): 34.
https://doi.org/10.1182/blood-2021-151658
Published: 2021